Skip to content

Orotracheal Intubation with the ORION Videolaryngoscope Versus the King Vision Videolaryngoscope in Adult Patients: ORION Trial

Orotracheal Intubation with the ORION Videolaryngoscope Versus the King Vision Videolaryngoscope in Adult Patients Without Predictors of a Difficult Airway

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06622538
Acronym
ORION
Enrollment
50
Registered
2024-10-02
Start date
2024-10-01
Completion date
2024-10-31
Last updated
2025-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

3D Printing, Anesthesia, Orotracheal Intubation, Videolaryngoscopes (VL)

Keywords

3d printing, Orotracheal intubation, videolaryngoscope, ORION, Additive Manufacturing

Brief summary

This study aims to compare the ORION video laryngoscope with the King Vision video laryngoscope for orotracheal intubation in patients without predictors of difficult airway scheduled for elective surgery under general anesthesia.

Detailed description

The video laryngoscope, compared to direct laryngoscopy, provides better visualization of the laryngeal and glottic structures, a higher success rate for intubation on the first attempt, and a lower incidence of complications such as mucosal injury, dental injury, and esophageal intubations. Despite the advantages offered by video laryngoscopy, its use is not widespread in developing countries due to high costs. For this reason, the ORION video laryngoscope was developed as a low-cost, reusable device that can undergo high-level disinfection. It is designed using additive manufacturing and meets the standards for biocompatibility, rigidity, and resistance. Additionally, it has undergone preclinical testing in simulation models where anesthesiologists have approved its use in real clinical scenarios. In this study, patients scheduled for elective surgery under general anesthesia without predictors of difficult airway will be included and randomized to be intubated with either the ORION video laryngoscope or the King Vision video laryngoscope. The study will compare the success of intubation on the first attempt, the time taken for intubation, the level of visualization of the glottic structures, and the associated complications between the two video laryngoscopes.

Interventions

DEVICEOrotracheal intubation

Patients who meet the inclusion criteria and sign the informed consent form will be intubated with the ORION or King Vision video laryngoscope according to randomisation.

Sponsors

Hospital General de México Dr. Eduardo Liceaga
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

Randomization in two groups

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients over 18 years of age scheduled for elective surgery requiring general anesthesia. * Patients without predictors of difficult airway. * Patients with ASA I-II classification. * Patients with BMI less than 35 kg/mts2.

Exclusion criteria

* Pregnant women. * Patients requiring emergency surgery. * Patients with chronic obstructive pulmonary disease. * Patients with a history of chronic ischemic heart disease. * Patients with a history of asthma. * Patients who have not signed the informed consent to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Successful first attemptAfter the endotracheal intubation completedMeasurement of orotracheal intubations obtained in the first attempt of videolaryngoscopy with the two videolaryngoscopes, successful orotracheal intubation will be corroborated by capnography. Measured in percentage (%).

Secondary

MeasureTime frameDescription
Laryngeal visualisation measured with the Cormack Lehane scaleAfter the endotracheal intubation completedMeasurement of visualization of glottic structures using the Cormack Lehane scale in grade I, II, II and IV obtained with both video laryngoscopes. Measured in percentage (%).
Laryngeal visualisation measured with the POGO scaleAfter the endotracheal intubation completedMeasurement of the visualization of the glottic structures using the POGO (Percentage of Glottic Opening) scale from 0% to 100% obtained with both video laryngoscopes. Measured in percentage (%).
Esophageal intubationAfter the endotracheal intubation completedMeasurement of the number of esophageal intubations obtained with both video laryngoscopes. Measured in percentage (%)
Intubation timeAfter the endotracheal intubation completedTime elapsed from the time the video laryngoscope blade crosses the dental arch until the orotracheal tube is inserted into the trachea, this time will be measured for each video laryngoscope. Measured in seconds (s).
Number of video laryngoscopy attemptsAfter the endotracheal intubation completedMeasurement of the number of video laryngoscopy attempts to successful intubation with both video laryngoscopes. Measurement in percentage (%)
Intubation failureAfter the endotracheal intubation completedThree videolaryngoscopies with duration of 120 seconds each without achieving orotracheal intubation. The number of intubation failures of both videolaryngoscopes will be measured in percentage (%).
ComplicationsAfter the endotracheal intubation completedMeasurement of complications (mucosal, lip, oral, pharyngeal and laryngeal injury, total or partial fracture of a tooth and Hypoxemia) that occur with the use of the ORION and King Vision Videolaryngoscopes. Measured in percent (%)

Countries

Mexico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026